Consolidating the role of*I-MIBG-scintigraphy in childhood neuroblastoma: Five years of clinical experience
- 1 January 1990
- journal article
- research article
- Published by Springer Nature in Pediatric Radiology
- Vol. 20 (3) , 157-159
- https://doi.org/10.1007/bf02012960
Abstract
In recent years,*I-MIBG (*I-metaiodobenzylguanidine), which is transported and stored in the chromaffin cells, has been shown to allow good visualization of neuroblastomas in children. This paper deals with 30*I-MIBG-scans performed in 20 children: 16 with neuroblastoma, 3 with retinoblastoma, and 1 with a malignant paraganglioma. A high detection rate was found for both primary and secondary sites of neuroblastoma.*I-MIBG was generally superior to99mTc-MDP bone scintigraphy in the detection of bone metastases. Our experience illustrates the unique place of*I-MIBG-scintigraphy compared with other imaging techniques: it makes it possible to define the nature of the tumour, particularly in cases with normal catecholamine levels; to establish how extensive the lesions are at the time of diagnosis; and to confirm complete remission. No abnormal*I-MIBG uptake was noted in the 3 cases of retinoblastoma.Keywords
This publication has 6 references indexed in Scilit:
- RADIONUCLIDE DIAGNOSIS AND THERAPY OF NEURAL CREST TUMORS USING I-131 METAIODOBENZYLGUANIDINE1987
- Local evaluation of abdominal neuroblastoma stage III and IV: use of US, CT, and 123 I-meta-iodobenzylguanidine (MIBG) scintigraphy.1987
- Metaiodobenzylguanidine (MIBG) labeled with 123I/131I in neuroblastoma diagnosis and follow‐up treatment with a review of the diagnostic results of the international workshop of pediatric oncology held in Rome, september 1986Medical and Pediatric Oncology, 1987
- 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomasSeminars in Nuclear Medicine, 1985
- Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine.1984
- RADIOLABELED ADRENERGIC NEURON-BLOCKING AGENTS - ADRENOMEDULLARY IMAGING WITH [I-131]IODOBENZYLGUANIDINE1980